The use of valproic acid and multiple sclerosis
Nete Munk Nielsen, Anders Hviid(Statens Serum Institut), Henrik Svanström(Statens Serum Institut), Björn Pasternak(Phoenix Children's Hospital), Egon Stenager(Copenhagen University Hospital), Nils Koch‐Henriksen(Aarhus University Hospital), Melinda Magyari(University of Copenhagen)
Cited by 13
Related Papers
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303
Childhood body mass index and multiple sclerosis risk: a long-term cohort study
|Multiple Sclerosis Journal|2013|297
Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis
|JAMA Neurology|2021|237
Apparent changes in the epidemiology and severity of multiple sclerosis
|Nature Reviews Neurology|2021|209
Comorbidity in Multiple Sclerosis
|Frontiers in Neurology|2020|204